P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM)
HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e04566c4
10.1097/01.hs9.0000970708.04566.c4